Everest Re Group, Ltd.
EG - NYSE - $351.52 ▼ -%0.06
-
Earnings Wed 29 Jul

Everest opens the
books on Wednesday evening.

4 analysts' median target is $365[FMP target], stock is $352, +3.8% upside potential. After Q1 +15.1% EPS beat[FMP earnings], the stock moved +3.7%.

↓ summary below
Quick Take - in 40 seconds
A+
HOLD Council 3/6 - Moonshot 34

A+ = MoonshotScore 34[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $4.1B[FMP est], EPS $14.58[FMP est]. 1 consecutive quarters of beat[FMP earnings].

Detailed analysis below ↓
$14.58 EPS Estimate Last year $13.26 - -16% YoY YoY
1 Beat Streak Expectations beaten consecutively for the last 1 quarters

Q1 EPS +15.1% beat[FMP] but the stock +3.7% D+1[FMP D+1]. Mark Kociancic promised $0 CapEx + a sequential decline in Q4 during the Q1 earnings call[Mark Kociancic capex transcript].

Watchlist

6 metrics stand out this quarter.

$2.6 billion Investor Focus

Mt Logan Aum Growth

mt_logan_aum_growth

Mt. Logan continues to build momentum with assets under management now exceeding $2.6 billion.

"Mt. Logan continues to build momentum with assets under management now exceeding $2.6 billion."

- James Williamson, President and CEO - Q1 FY26 Earnings Call - April 30, 2026
$200 million Investor Focus

Share Repurchase Increase

share_repurchase_increase

Everest is increasing its share repurchases, signaling confidence that its share price is undervalued.

"Effective this quarter, we are raising the quarterly floor on share repurchases from $200 million to $300 million, absent major external dislocation. This reflects our continued conviction that Everest share price today does not accurately reflect either the current value or the true earnings power of the company."

- James Williamson, President and CEO - Q1 FY26 Earnings Call - April 30, 2026
3.8% Investor Focus

Global Wholesale Specialty Improvement

global_wholesale_specialty_improvement

Everest's Global Wholesale & Specialty saw a 3.8% improvement in loss experience driven by shifting the portfolio towards short-tail lines and strengthening the quality of the portfolio.

"And while it's early, we believe mix benefits from our actions to shift the portfolio towards short-tail lines and to strengthen the quality of the portfolio are driving improved loss experience. These actions contributed a 3.8% improvement in our attritional loss ratio to 58.9%, while we continue to set prudent loss picks."

- Mark Kociancic, Executive Vice President and CFO - Q1 FY26 Earnings Call - April 30, 2026
$315 million Investor Focus

Treaty Reinsurance Performance

treaty_reinsurance_performance

Everest's Treaty Reinsurance segment delivered a strong quarter with a combined ratio of 87.2%.

"Treaty Reinsurance delivered an excellent quarter, generating $315 million of underwriting income on an 87.2% combined ratio."

- James Williamson, President and CEO - Q1 FY26 Earnings Call - April 30, 2026
$1.2 billion Investor Focus

Casualty Premium Reduction

casualty_premium_reduction

Everest has reduced casualty premium by more than $1.2 billion since January 2024.

"Since January 2024, we have reduced casualty premium by more than $1.2 billion."

- James Williamson, President and CEO - Q1 FY26 Earnings Call - April 30, 2026
13% Investor Focus

Property Catastrophe Pricing Softening

property_catastrophe_pricing_softening

Everest notes that property catastrophe pricing continued to soften with rate down 13% on their book globally.

"Property Catastrophe pricing continued to soften with rate down 13% on our book globally."

- James Williamson, President and CEO - Q1 FY26 Earnings Call - April 30, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

MoonshotScore 34 / 100

9-pillar methodology. Price Momentum strong. Revenue Growth weak.

How is it calculated? ->
Revenue Growth0.0Q1 vs Q2: growth negative (-7.6%, contraction)
Gross Margin5.0Q1: average margin (45.5%)
Operating Leverage2.0op margin healthy (18.1%)
Cash Runway3.0FCF very strong ($0.6B, 649000000.0x CapEx)
R&D Intensity3.0low R&D investment (0.0%, weak innovation)
Price Momentum7.0RSI 58.4 positive momentum, 50d above
News Sentiment4.0mixed (38% buy)
Council Score 3 / 6 Bullish

6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +3.8%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 58
Klarman value - target upside +3.8%
Buffett quality - ROE score 4/5
Munger valuation - target upside +3.8%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthStrong
Margin of SafetyWeak
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
58.4 RSI 58.4 positive momentum, 50d above
MACD
+4.90 price above 50d - support positive
50d MA
$335 stock 4.9% above - short-term support
200d MA
$333 stock 5.4% above - long-term support
Volume (10d)
-22% decrease - low participation
Resistance
$365
Analyst median target - upgrade trigger if broken
Current
$352
Pre-earnings position
Support
$283
Invalidation - close below this is a technical breakdown
Pattern
Range
$283-$365 band - earnings breakout/breakdown trigger

Past Performance

Everest's last 8 quarters: 1 consecutive beats.

BEAT
Q2 FY25
$17.36 vs $15.14 est - +1.0%
MISS
Q3 FY25
$7.54 vs $14.63 est - -11.4%
MISS
Q4 FY25
$13.26 vs $13.36 est - -2.3%
BEAT
Q1 FY26
$16.08 vs $13.97 est - +3.7%

Q1 (April 30, 2026): EPS $16.08 vs $13.97 est[FMP], +15.1% beat. D+1 movement: +3.7%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $14.14 (no guidance)

Q1: EPS $16.08 vs $13.97 beat[FMP], stock +3.7% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $0[FMP cashflow]. Q1 op margin 18.1%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $14.58 + CapEx discipline
Threshold: EPS > $14.58[FMP est].
Target: Break above median target $365[FMP target]; high target $377[FMP] upper bound.
Scenario B - In-Line
EPS approx $14.58 + CapEx < $0
Threshold: EPS approx $14.58[FMP est], Q4 CapEx < $0[FMP].
Target: Consolidation in the band between current $352[FMP] and median $365[FMP].
Scenario C - Miss
EPS < $14.14 or CapEx >= $0
Threshold: EPS < $14.14[FMP estx0.97].
Target: Current $352 below SMA200 $333[FMP], if rejection continues, $283[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 4 analysts say?

Wall Street Consensus
$365
12-month median target price (+3.8% upside potential)
6
BUY
10
HOLD
0
SELL
Risk Management
$283
Invalidation level - critical support threshold
$335 - 50-day MA (above, +4.9%)
$333 - 200-day MA (above, +5.4%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - EG Q4 FY26
A+

You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Wednesday evening. The framework is ready on this page: Q4 EPS threshold $14.58[FMP], CapEx threshold "below $0"[Mark Kociancic]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Try Pro free for 14 days EG dossier ->

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 29, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jul 30, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 12, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Oct 29, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the EG earnings preview cover?

This EG (EG) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in EG earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.